Previous 10 | Next 10 |
home / stock / cgn:cc / cgn:cc news
Company to provide its AI-powered cognitive assessment technology to policyholders in Japanese market to promote proactive approach to brain health Vancouver, British Columbia--(Newsfile Corp. - April 25, 2023) - Cognetivity Neurosciences Ltd. (CSE: CGN) (OTCQB: CGNSF) (FSE: 1UB) ...
Appointment brings deep industry and investment experience to the company, helping the company's expansion and growth globally Vancouver, British Columbia--(Newsfile Corp. - April 20, 2023) - Cognetivity Neurosciences Ltd. (CSE: CGN) (OTCQB: CGNSF) (FSE: 1UB) (the "Company" or "Co...
Company presents key data on measuring impact of sleep disorders on brain health; University of Oxford extends collaboration on monitoring changes in cognition of older adults Vancouver, British Columbia--(Newsfile Corp. - March 23, 2023) - Cognetivity Neurosciences Ltd. (CSE: CGN) (OTCQ...
Expansion of first-phase deployment follows excellent published results, showing cross-cultural validity, leading to further expansion and market traction in Asia Vancouver, British Columbia--(Newsfile Corp. - March 8, 2023) - Cognetivity Neurosciences Ltd. (CSE: CGN) (OTCQB: CGNSF) ...
Latest Agreement Signals Continued, Rapid Commercial Growth in Middle East Region Vancouver, British Columbia--(Newsfile Corp. - February 23, 2023) - Cognetivity Neurosciences Ltd. (CSE: CGN) (OTCQB: CGNSF) (FSE: 1UB) (the "Company" or "Cognetivity") , a technology company that ...
Peer-reviewed article demonstrates effectiveness of company's technology in major disease area with global application for the detection and monitoring of disease Vancouver, British Columbia--(Newsfile Corp. - February 22, 2023) - Cognetivity Neurosciences Ltd. (CSE: CGN) (FSE: 1UB) (OTCQB: CGNS...
With global interest in AI at an all-time high, latest update to Cognetivity's flagship medical device affirms company's sustained commitment to being at the forefront of AI in healthcare Vancouver, British Columbia--(Newsfile Corp. - February 14, 2023) - Cognetivity Neurosciences Ltd. (CSE: CG...
Demonstrable sensitivity and clinical usability of Cognetivity's screening and monitoring tool leaves the company well placed to support the dawning era of targeted therapies for neurodegenerative disease Vancouver, British Columbia--(Newsfile Corp. - January 24, 2023) - Cognetivity Neuroscienc...
Key achievements in 2022 included continued collaboration with global pharmaceutical firms working in neurodegenerative disease, new and ongoing commercial deployments spanning three continents, and completion of a fundraising round worth CAD 4.5 million Vancouver, British Columbia--(Newsfile Co...
Policy paper published by UK's leading dementia research charity emphasizes importance of early detection in dementia diagnosis, citing Cognetivity's CognICA(TM) as an innovative solution for use in primary care Vancouver, British Columbia--(Newsfile Corp. - December 13, 2022) - Cognetivity Neu...
News, Short Squeeze, Breakout and More Instantly...
Cognetivity Neurosciences Ltd. Company Name:
CGN:CC Stock Symbol:
CNQC Market:
Cognetivity Neurosciences Ltd. Website:
Velan Inc. Subordinate Voting Shares (VLN:CA) is expected to report for Q1 2025 GoldMining Inc. (GOLD:CA) is expected to report $-0.02 for Q2 2024 Blue Star Gold Corp. (BAU:CA) is expected to report for Q2 2024 Organigram Holdings Inc. (OGI:CA) is expected to report $-0.07 for Q3 2024...
Richelieu Hardware Ltd. (RCH:CA) is expected to report $0.42 for Q2 2024 Goodfellow Inc. (GDL:CA) is expected to report for Q2 2024 Centamin plc Ordinary Shares (CEE:CA) is expected to report for Q1 2024 Velan Inc. Subordinate Voting Shares (VLN:CA) is expected to report for Q1 2025 ...
Canadian Investment Regulatory Organization Trading Halt - CGN Canada NewsWire VANCOUVER, BC , June 6, 2024 /CNW/ - The following issues have been halted by CIRO: Company: Cognetivity Neurosciences Ltd. CSE Symbol: CGN All Issues: Yes Reason: Cease Tr...